Literature DB >> 6347471

Cyclosporin A inhibits acute serum sickness nephritis in rabbits.

G H Neild, K Ivory, M Hiramatsu, D G Williams.   

Abstract

The effect of the immunosuppressive agent cyclosporin A (Cy A) on the renal injury in acute serum sickness was examined in rabbits. Serum sickness was induced in 23 untreated NZW rabbits by a single intravenous injection of bovine serum albumin (BSA) 250 mg/kg with E. coli endotoxin (5 micrograms/kg): BSA was eliminated after 8.6 +/- 0.16 days (mean +/- s.e. (mean]; proteinuria occurred in 19 (84%) and glomerular proliferation in 20 (87%) rabbits. When Cy A (15 or 25 mg/kg) was given daily by intramuscular injection, starting either 2 days before or at the time of induction of acute serum sickness, proteinuria was profoundly reduced and glomerular proliferation was inhibited. Even when rabbits were first treated with Cy A (25 mg/kg) 5 days after the induction of disease proteinuria and glomerular proliferation were similarly inhibited. When the treated animals were compared with controls there were no differences in the following: time to elimination of BSA, amount or size of circulating immune complexes, fall in serum C3 at immune elimination, or deposition of immune reactants in the glomeruli. These results show that Cy A inhibits the renal injury of acute serum sickness and indicate that T cells may play a role in mediating the nephritis in this condition.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6347471      PMCID: PMC1536029     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Pathogenesis of serum sickness.

Authors:  F J DIXON; J J VAZQUEZ; W O WEIGLE; C G COCHRANE
Journal:  AMA Arch Pathol       Date:  1958-01

2.  Cyclosporin A: an immunosuppressive agent preferentially active against proliferating T cells.

Authors:  D J White; A M Plumb; G Pawelec; G Brons
Journal:  Transplantation       Date:  1979-01       Impact factor: 4.939

Review 3.  Cyclosporin A.

Authors:  P J Morris
Journal:  Transplantation       Date:  1981-11       Impact factor: 4.939

4.  Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process.

Authors:  E L Larsson
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

5.  Immune complex-dependent T cell-mediated cytostasis (IDTC).

Authors:  J Tanaka; J Yata
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

6.  Induction of specific tolerance in rabbits by kidney allografting and short periods of cyclosporin-A treatment.

Authors:  C J Green; A C Allison; S Precious
Journal:  Lancet       Date:  1979-07-21       Impact factor: 79.321

7.  Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.

Authors:  R B Nussenblatt; M M Rodrigues; W B Wacker; S J Cevario; M C Salinas-Carmona; I Gery
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

8.  Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury.

Authors:  H Shulman; G Striker; H J Deeg; M Kennedy; R Storb; E D Thomas
Journal:  N Engl J Med       Date:  1981-12-03       Impact factor: 91.245

9.  Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2.

Authors:  D Bunjes; C Hardt; M Röllinghoff; H Wagner
Journal:  Eur J Immunol       Date:  1981-08       Impact factor: 5.532

10.  The role of monocytes in serum sickness nephritis.

Authors:  L G Hunsicker; T P Shearer; S B Plattner; D Weisenburger
Journal:  J Exp Med       Date:  1979-09-19       Impact factor: 14.307

View more
  8 in total

1.  Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: II. Reduction of glomerulonephritis.

Authors:  H C Gunn; B Ryffel
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

Review 2.  The treatment of immune glomerular disease.

Authors:  D G Williams
Journal:  Springer Semin Immunopathol       Date:  1987

3.  Acute serum sickness in normal and C6 deficient rabbits: role of membrane attack complex.

Authors:  G Parra; Y Takekoshi; J Striegel; R L Vernier; A F Michael
Journal:  Int J Exp Pathol       Date:  1992-06       Impact factor: 1.925

4.  Rituximab-induced serum sickness in a girl with nephrotic syndrome.

Authors:  Yuka Kimura; Kyoko Kiyota; Mayo Ikeuchi; Kazuhito Sekiguchi; Kenji Ihara
Journal:  CEN Case Rep       Date:  2022-05-20

Review 5.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 6.  Acute leucoencephalopathy during cyclosporin A therapy in a patient with nephrotic syndrome.

Authors:  C Shimizu; S Kimura; Y Yoshida; A Nezu; K Saitoh; H Osaka; Y Aihara; Y Nagasaka
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

7.  Participation of the interstitium in acute immune-complex nephritis: interstitial antigen accumulation, cellular infiltrate, and MHC class II expression.

Authors:  G Parra; S Hernández; P Moreno; B Rodríguez-Iturbe
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

8.  Prolongation of life in female NZB/NZW (F1) hybrid mice by cyclosporin A.

Authors:  M G Jones; G Harris
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.